Hemostasis Today

October, 2026
October 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Sandrine Oziel-Taieb: Hematological Toxicity Management During Lu-Dotatate
Sep 5, 2026, 14:50

Sandrine Oziel-Taieb: Hematological Toxicity Management During Lu-Dotatate

Sandrine Oziel-Taieb, Medical Oncologist at the Paoli Calmettes Institute, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in EJNMMI, adding:

“Our national survey on hematological toxicity management during Lu Dotatate is now published in the European Journal of Nuclear Medicine and Molecular Imaging.

The LutaVire survey, conducted under the auspices the GTE, SFMN and endocan renaten network, highlights substantial real-world heterogeneity in how clinicians manage thrombocytopenia and long term bone marrow safety during PRRT, and underscores the need for harmonized, individualized monitoring guidelines.

Thank you to all 40 expert physicians who contributed, and to my co autors Magalie Haissaguerre, Catherine Ansquer, Emmanuel Deshayes, and Ghoufrane Tlili.”

Title: Managing hematological toxicity in Lu-DOTATATE for NET patients: a national survey from the French group of endocrine tumors (GTE) on the clinical need for harmonized monitoring strategies

Authors: S. Oziel-Taieb, C. Ansquer, G. Tlili, E. Deshayes, M. HaissaguerreSandrine Oziel-Taieb: Hematological Toxicity Management During Lu-Dotatate

Stay updated on all scienntific advances with Hemostasis Today.